Have you heard about the new Bayer Co.Lab? Designed to support #cellandgenetherapy entrepreneurs, the Bayer Co.Lab provides access to Bayer's extensive expertise and a state-of-the-art lab and office space (operated by yours truly 😉) Apply here: labcentral.site/3Nt1WyV

New art alert! 🎨 SelfMade Designs, a collective of artists in the Greater Boston area, have taken over the walls of #Gallery1832 at LabCentral 238. If you're in our 238 location, or at the new #BayerCoLab come check it out!

When #Asimov's team needed access to an #HPLC system to confirm some last-minute data before a webinar, they contacted LabCentral for help. Whether your #startup is a current resident, or has graduated into the alumni status – we're here to help empower #innovation

Amazing news from one of our 238 resident companies! May their #clinicaltrial bring great responses. #WhereBiotechBegins #PuttingLifeInLifeSciences

#Gallery1832 is back with another art reception –this time highlighting #sustainability 🌱 come celebrate our latest installation 'Catch & Release' sponosred by Triumvirate 📅 Date: October 4th 🕕 Time: 4:30pm - 6:30pm 📍 Location: 700 Main St. ✉️ RSVP: bit.ly/3RuCzjQ

Today LabCentral was taken on a food tour around the world with our 3rd annual #CulturalCelebration! Residents, sponsors and partners came together to represent 20 countries through food, drink and dress 🤩 Thank you to everyone who attended! Now, time for our #foodcoma 🥴

And we're off! Today we're holding our first ever Leadership Summit, aptly titled "What's Next" 🤔💡 As our resident founders and CEOs navigate their biotech & life sciences startups, it seems like the question on many minds is, 'what's next?' Today, we've gathered expert

In honor of #WorldDiabetesDay, we're featuring one of our resident companies– i2o Therapeutics. I2o aims to address type 2 diabetes through all-oral regimens & implantable therapies. This comes at a pivotal time, as experts say diabetes could impact 1.3 billion people by 2050.

Incredible dialogue last night between Sean K. Ellis and Mayor E. Denise Simmons on the enduring systemic racism in our justice system & the struggles faced by exonerees long after release. Check out the work being done by the New England Innocence Project to get involved. #socialimpact

Excited to announce the Diamond Ticket in partnership with Astellas Pharma US! We're looking to award one powerhouse biotech startup with private lab space at our LabCentral 238 location, a value of $500,000. Applications close April 5th! Learn more below 👇👇 prnewswire.com/news-releases/…

Today we're pleased to announce the release of our 2023 Impact Report, detailing a decade of groundbreaking #innovation and economic growth for biotech and life sciences #startups at LabCentral! To read to full report head to the link below! 👇👇 labcentral.org/2023-impact-re…

🫣 Sneak peek below! 🫣 Introducing ‘The Dish with Johannes’! Join LabCentral’s President, Johannes Fruehauf, as he dives into biotech's dynamic world. 🌟 From startups to investor decisions and industry leader support, hear stories shaping biotech's future. Tune in for

It's here! The first full episode of our new video series, 'The Dish with Johannes' is out on our Youtube channel! 🧫🔬 Full episode here 👉 lnkd.in/eTgUHdfd In our premiere episode, Johannes Fruehauf🇺🇦 sits down with Katrine Bosley to hear more about her latest startup venture –

On #WorldBrainDay we're asking a question that came from our most recent conversation between Johannes Fruehauf🇺🇦 and Katrine Bosley. Could #triculture systems like the one in the video below ultimately replace traditional #animalcell culture systems? 🧠🤔 Catch the full episode of The

STARTING NOW: Johnson & Johnson is at LabCentral talking all things Oncology. Featuring a presentation with follow up panels this is one you don't want to miss! See agenda here: labcentral.swoogo.com/jnjoncology

🔊 Calling biotech entrepreneurs! Join today’s @NCIsbir Development Center webinar (2:00-3:30 PM) for an overview of the PHS 2025-I Contract Solicitation. Learn about early-stage cancer tech funding & 13 NCI topics. Q&A session included. Register now: bit.ly/3MBoQEl